发明公开
EP1266221A1 MAGE ANTIGENIC PEPTIDES WHICH BIND HLA-B35 AND HLA-B44
审中-公开
AN HLA-B35 UND HLA-B44 BINDENDE MAGE ANTIGENE肽
- 专利标题： MAGE ANTIGENIC PEPTIDES WHICH BIND HLA-B35 AND HLA-B44
- 专利标题（中）： AN HLA-B35 UND HLA-B44 BINDENDE MAGE ANTIGENE肽
-
申请号： EP01913365.1申请日： 2001-01-19
-
公开(公告)号： EP1266221A1公开(公告)日： 2002-12-18
- 发明人: LUITEN, Rosalie , BOON-FALLEUR, Thierry , VAN DER BRUGGEN, Pierre , STROOBANT, Vincent , DEMOTTE, Nathalie , SCHULTZ, Erwin
- 申请人： LUDWIG INSTITUTE FOR CANCER RESEARCH
- 申请人地址： 605 Third Avenue New York,New York 10158 US
- 专利权人： LUDWIG INSTITUTE FOR CANCER RESEARCH
- 当前专利权人： LUDWIG INSTITUTE FOR CANCER RESEARCH
- 当前专利权人地址： 605 Third Avenue New York,New York 10158 US
- 代理机构： Harrison Goddard Foote
- 优先权： US177242P 20000120; US243212P 20001025
- 国际公布： WO01053833 20010726
- 主分类号： G01N33/53
- IPC分类号： G01N33/53 ; A61K35/14 ; C07K14/47 ; C12N15/12
摘要：
The invention provides antigenic peptides derived from MAGE-A1 polypeptides and presented by HLA-B35 and HLA-B44 molecules. Antigenic peptides derived from MAGE-A3 polypeptides and presented by HLA-B35 molecules also are provided. Methods for diagnosis and treatment which involve the polypeptides also are provided.
信息查询
IPC分类:
